Publications by authors named "Gizem Nemutlu"
Background & Aims: Guidelines recommend biannual surveillance for hepatocellular carcinoma (HCC) in hepatitis C individuals with cirrhosis if the HCC incidence rate is above 1.5 per 100 person-years (PY). However, the incidence threshold for surveillance in individuals who achieve a virologic cure is unknown.
View Article and Find Full Text PDFArticle Synopsis
- Successful treatment of chronic hepatitis C with oral DAAs can lead to a viral cure, but patients still face an ongoing risk of developing hepatocellular carcinoma (HCC), prompting the need for surveillance.
- A microsimulation model was used to assess the cost-effectiveness of biannual HCC surveillance for patients who have been cured, comparing varying durations of monitoring against no surveillance.
- Results showed that biannual surveillance is cost-effective for cured patients, detecting more early-stage HCC cases and yielding additional quality-adjusted life years, with optimal surveillance stopping at age 70 for cirrhosis patients and age 60 for those with advanced fibrosis.
Human papillomavirus (HPV)-associated anal and oropharyngeal cancer incidence has increased in recent years among US women. However, trends in incidence and burden (annual number of cases) of noncervical HPV-associated cancers relative to cervical cancer remain unclear. Using the 2001-2017 US cancer statistics dataset, we evaluated contemporary incidence trends and burden (annual number of cases) of HPV-associated cancers among women by anatomic site, race or ethnicity, and age.
View Article and Find Full Text PDFThis cross-sectional study investigates the prevalence of human papillomavirus (HPV) infection among US women who received between 0 and 3 doses of HPV vaccine.
View Article and Find Full Text PDFThis cross-sectional survey study assesses knowledge of human papillomavirus by age and sex.
View Article and Find Full Text PDF